Aguirre MCA, Espínola ZN, Córdova GF

Language: Spanish
References: 22
Page: 290-296
PDF size: 131.98 Kb.

ABSTRACT

The cardiomyopathies are defined as a primary disease of the myocardium and occur in children as well as in adults. Restrictive cardiomyopathy is the least common type of cardiomyopathy and is characterized by the restriction of ventricular filling. This condition can affect one or both ventricles. The appropriate diagnostic tool includes a detailed clinical record supported by imaging and hemodynamic studies. The purpose of this study was to evaluate adult patients with suspicion of restrictive miocardiopathy of the right ventricle, from the out-patients clinic using echocardiogram, magnetic resonance imaging, and hemodynamic studies and to establish a differential diagnosis with other cardiovascular diseases. Between May 2003 to January 2006 three patients with different initial diagnoses, such as Ebstein’s anomaly, interatrial septal defect, and tumor of the right ventricle were studied. However, once the protocol of the study was completed, the final diagnosis was of right ventricular restrictive cardiomyopathy by endomyocardial fibrosis.

REFERENCES

1. KUSHWAHA SS, FALLON JT, FUSTER V: Restrictive cardiomyopathy. New Engl J Med 1997; 336(4): 267-277.

2. HUGHES SE, MCKENNA WJ: New Insights into the pathology of inherited cardiomyopathy. Heart 2005; 91: 257-264.

3. RICHARSON P, MC KENNA WJ, BRISTOW M, MAISCH B, MAUTNER B, O’CONNELL J, ET AL: Report on the 1995 WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-42.

4. WOOD MJ, PICARD MH: Utility of Echocardiography in the evaluation of individuals with cardiomyopathy. Heart 2004; 90: 707-712.

5. KJAERGAARD J, PETERSEN CL, KJAER A, SCHAADT BK, OH JK, HASSAGER C: Evaluation of right ventricular volume and function by 2D and 3D echocardiography compared to MRI. Eur J Echocardiography 2005; 8: 1-10.

6. RAJAGOPALAN N, GARCIA MJ, RODRIGUEZ L, MURRAY DR, APPERSON-HANSEN C, STUGAARD M, ET AL: Comparison of New Doppler Echocardiographic Methods to differentiate constrictive pericardial heart disease and restrictive cardiomyopathy. Am J Cardiol 2001; 87: 86–94.

7. GUTIÉRREZ ZAMORA A: Abordaje diagnóstico de las miocardiopatías mediante resonancia magnética. Arch Cardiol Méx 2005; 75: 90-95.

8. GROTHUES F, MOON JC, BELLENGER NG, SMITH GS, KLEIN HU, PENNEL DJ: Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004; 147(2): 218-223.

9. SOMERS K, HUTT MS, PATEL AK, D´ARBELA PG: Endomyocardial biopsy in diagnosis of cardiomyopathies. Br Heart J 1971; 33: 822-832.

10. DAVIES JNP: Obscure disease affecting mural endomiocardium. Am Heart J 1960; 59: 600-631.

11. CONNOR DH, SOMERS K, HUTT MSR, MANION WC, D’ARBELA PG: Endomyocardial fibrosis in Uganda (Davies´disease): Part I Epidemiologic,clinical and pathologic study. Am Heart J 1967; 74: 687-709.

12. CONNOR DH, SOMERS K, HUTT MSR, MANION WC, D’ARBELA PG: Endomyocardial fibrosis in Uganda (Davies’ disease): Part II Epidemiologic, clinical and pathologic study. Am Heart J 1968; 75: 107-124.

13. DAVIES JM: The Cardiomyopathies: an overview. Heart 2000; 83: 469-474.

14. GRAHAM JM, LAWRIE GM, FETEIH NM, DEBAKEY ME: Management of endomyocardial fibrosis: Successful surgical treatment of biventricular involvement and consideration of the superiority of operative intervention. Am Heart J 1981; 102: 771-775.

15. OAKLEY CM, OLSEN EGJ: Eosinophilia and heart disease. Br Heart J 1977; 39: 233-237.

16. MURPHY RT, STARLING RC: Genetics and cardiomyopathy: Where are we now? Cleveland Clinic J Med 2005; 72(6): 465-483.

17. FASAND R, RIMMERMAN CM, JABER WA: Cardiac Sarcoidosis: A cause of infiltrative cardiomyopathy. Cleveland Clinic J Med 2004; 71(6): 483–489.

18. HASSAN WM, FAWZY ME, HELALY SA, HEGAZY H, MALIK S: Pitfalls in diagnosis and clinical echocardiographic, and hemodynamic findings in endomyocardial fibrosis. A 25-year experience. Chest 2005; 128: 3985-3982.

19. GOLDSTEIN JA: Cardiac Taponade, constrictive pericarditis, and restrictive cardiomyopathy. Curr Probl Cardiol 2004; 29: 503-567.

20. ACQUATELLA H, SCHILLER NB, PUIGBO JJ, GOMEZMANCEBO JR, SUAREZ C, ACQUATELLA G: Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. Circulation 1983; 67: 1219-1226.

21. GROTHUES F, SMITH GC, MOON JC, BELLENGER NG, COLLINS P, KLEIN HU, ET AL: Comparison interstudy reproducibility of cardiovascular magnetic resonance with two dimensional echocardiography in normal subjects and in patients with heart failure at left ventricular hypertrophy. Am J Cardiol 2002; 90(1): 29-34.

22. CHERIAN G, VIJAYARAGHAVAN G, KRISHNASWAMI S, SUKUMAR IP, JOHN S, JAIRAJ PS, ET AL: Endomyocardial fibrosis: report of hemodynamic data in 29 patients and review of the results of surgery. Am Heart J 1983; 105: 659-666.